SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) January 4, 2001
----------------
Generex Biotechnology Corporation
-------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 000-25169 98-0178636
----------------- ------------- -------------------
(State or other (Commission (IRS Employer
jurisdiction of Incorporation) File Number) Identification No.)
33 Harbour Square, Suite 202, Toronto, Ontario Canada M5J 2G2
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 416/364-2551
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events.
Effective as of January 4, 2002, the Board of Directors of Generex
Biotechnology Corporation (the "Company") fixed the date, time, location and
record date for the annual meeting of the stockholders of the Company for the
2001 fiscal year. The Board of Directors determined that the annual meeting of
the Company will be held on Monday, March 18, 2002 at 10:00 a.m. (local time) at
St. Lawrence Hall, 157 King Street East, Toronto, Ontario, Canada M5E 1C4. The
Board of Directors also established the close of business on February 4, 2002 as
the record date for the determination of stockholders entitled to receive notice
of, and to vote at, the annual meeting and any adjournment or postponement
thereof.
Stockholder Proposals
Any proposals of stockholders intended to be presented at the annual
meeting of stockholders for fiscal year 2001 were required to be received by the
Company at the principal executive offices of the Company no later than
September 1, 2001 in order to be included in the proxy materials for such
meeting. Such proposals were required to meet the requirements set forth in the
rules and regulations of the Securities and Exchange Commission in order to be
eligible for inclusion in the proxy materials for such meeting.
For business to be properly brought before the annual meeting by a
stockholder in a form other than a stockholder proposal, the stockholder must
give timely notice of such business in writing to the Secretary of the Company.
To be timely, a stockholder's notice must be delivered to or mailed and received
at the principal executive offices of the Company no later than the close of
business on January 18, 2002. A stockholder's notice to the Secretary must set
forth the following information as to each matter the stockholder proposes to
bring before the meeting:
o a brief description of the business desired to be brought before the
meeting and the reasons for conducting such business at the meeting;
o the name and address, as they appear on the Company's books, of the
stockholder proposing such business;
o the class and number of shares of the Company's capital stock which
are beneficially owned by the stockholder; and
o any material interest of the stockholder in such business.
Director Nominations
A stockholder of the Company entitled to vote for the election of
directors at the annual meeting may nominate a candidate for election to the
Board of Directors provided the stockholder gives timely notice of his or her
intention to make such nomination. The notice must be in writing to the
Secretary of the Company, and must be delivered to or mailed and received at the
principal executive offices of the Company no later than the close of business
on January 18, 2002. The notice must set forth the following information
relating to the nominee whom the stockholder proposes to nominate for election
or re-election as a director:
o the name, age, business address and residence address of the
nominee;
o the principal occupation or employment of the nominee;
o the class and number of shares of the Company which are beneficially
owned by the nominee; and
o any other information relating to the nominee that is required to be
disclosed in solicitations of proxies for the election of directors
or otherwise is required pursuant to Regulation 14A under the
Securities Exchange Act of 1934.
In addition, the notice must set forth the following information relating
to the stockholder giving the notice:
o the name and address, as they appear on the Company's books, of such
stockholder and
o the class and number of shares of the Company which are beneficially
owned by such stockholder.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
GENEREX BIOTECHNOLOGY CORPORATION
Dated: January 7, 2002 By: /s/ E. Mark Perri
--------------- -------------------------------
E. Mark Perri, Chairman and CFO